KYNB
KYNTRA BIO, INC.
Key Financials
Net Income
$183.5M
↑ 485.6%
Revenue
$6.4M
↓ 78.3%
EPS (Diluted)
$45.37
↑ 9552.1%
Total Assets
$119.6M
↓ 44.3%
Total Liabilities
$115.1M
↓ 71.1%
Shareholders' Equity
$-30038000.00
↑ 86.7%
Operating Income
$-45895000
↑ 69.5%
Long-term Debt
$75.0M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | KYNB |
| Company Name | KYNTRA BIO, INC. |
| CIK | 921299 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 415-978-1200 |